BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16269426)

  • 21. Involvement of the p38 MAPK signaling pathway in S-phase cell-cycle arrest induced by Furazolidone in human hepatoma G2 cells.
    Sun Y; Tang S; Jin X; Zhang C; Zhao W; Xiao X
    J Appl Toxicol; 2013 Dec; 33(12):1500-5. PubMed ID: 23112108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines.
    Ganapathi MK; May LT; Schultz D; Brabenec A; Weinstein J; Sehgal PB; Kushner I
    Biochem Biophys Res Commun; 1988 Nov; 157(1):271-7. PubMed ID: 2461709
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats.
    Koch DA; Silva RB; de Souza AH; Leite CE; Nicoletti NF; Campos MM; Laufer S; Morrone FB
    Rheumatology (Oxford); 2014 Mar; 53(3):425-32. PubMed ID: 24241037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes.
    Yap SH; Moshage HJ; Hazenberg BP; Roelofs HM; Bijzet J; Limburg PC; Aarden LA; van Rijswijk MH
    Biochim Biophys Acta; 1991 Feb; 1091(3):405-8. PubMed ID: 2001421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of p38 mitogen-activated protein kinase inhibitor SB203580 to glucocorticoid sensitivity].
    Li W; Lin JT; Sun LC; Zhou TL; Zhang L; Shu J
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(36):2570-3. PubMed ID: 23158801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma.
    Iyoda K; Sasaki Y; Horimoto M; Toyama T; Yakushijin T; Sakakibara M; Takehara T; Fujimoto J; Hori M; Wands JR; Hayashi N
    Cancer; 2003 Jun; 97(12):3017-26. PubMed ID: 12784337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p38 MAPK, but not ERK1/2, is critically involved in the cytotoxicity of the novel vascular disrupting agent combretastatin A4.
    Quan H; Xu Y; Lou L
    Int J Cancer; 2008 Apr; 122(8):1730-7. PubMed ID: 18074350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and regulation of constitutive and acute phase serum amyloid A mRNAs in hepatic and non-hepatic cell lines.
    Steel DM; Donoghue FC; O'Neill RM; Uhlar CM; Whitehead AS
    Scand J Immunol; 1996 Nov; 44(5):493-500. PubMed ID: 8947601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p38 MAPK and COX2 inhibition modulate human chondrocyte response to TGF-beta.
    Studer RK; Chu CR
    J Orthop Res; 2005 Mar; 23(2):454-61. PubMed ID: 15734262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel 1,4-naphthoquinone derivatives induce apoptosis via ROS-mediated p38/MAPK, Akt and STAT3 signaling in human hepatoma Hep3B cells.
    Liu C; Shen GN; Luo YH; Piao XJ; Jiang XY; Meng LQ; Wang Y; Zhang Y; Wang JR; Wang H; Xu WT; Li JQ; Liu Y; Wu YQ; Sun HN; Han YH; Jin MH; Cui YD; Fang NZ; Jin CH
    Int J Biochem Cell Biol; 2018 Mar; 96():9-19. PubMed ID: 29326072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Amyloid A Induces a Vascular Smooth Muscle Cell Phenotype Switch through the p38 MAPK Signaling Pathway.
    Zhang X; Chen J; Wang S
    Biomed Res Int; 2017; 2017():4941379. PubMed ID: 28642873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD14 is an acute-phase protein.
    Bas S; Gauthier BR; Spenato U; Stingelin S; Gabay C
    J Immunol; 2004 Apr; 172(7):4470-9. PubMed ID: 15034063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of C-reactive protein by cytokines in human hepatoma cell lines is potentiated by caffeine.
    Ganapathi MK; Mackiewicz A; Samols D; Brabenec A; Kushner I; Schultz D; Hu SI
    Biochem J; 1990 Jul; 269(1):41-6. PubMed ID: 2165398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of p38 mitogen-activated protein kinase in regulating interleukin-10 gene expression in Burkitt's lymphoma cell lines.
    Horie K; Ohashi M; Satoh Y; Sairenji T
    Microbiol Immunol; 2007; 51(1):149-61. PubMed ID: 17237610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin C downregulates interleukin-18 production by increasing reactive oxygen intermediate and mitogen-activated protein kinase signalling in B16F10 murine melanoma cells.
    Cho D; Hahm E; Kang JS; Kim YI; Yang Y; Park JH; Kim D; Kim S; Kim YS; Hur D; Park H; Pang S; Hwang YI; Lee WJ
    Melanoma Res; 2003 Dec; 13(6):549-54. PubMed ID: 14646616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum amyloid A promotes the inflammatory response via p38-MAPK/SR-BI pathway in THP-1 macrophages].
    Zhu MY; Wang Y; Wang Y; Peng FL; Ou HX; Zheng X; Shi JF; Zeng GF; Mo ZC
    Sheng Li Xue Bao; 2016 Jun; 68(3):293-300. PubMed ID: 27350202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P38 MAP-kinase pathway is involved in the production of CLC-3 in nasal epithelial cells with allergic rhinitis induced by interleukin-4.
    Han D; Zhou B; Cheng L; Oh Y; Li H
    Laryngoscope; 2006 Nov; 116(11):1973-7. PubMed ID: 17075426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone.
    Smith JW; McDonald TL
    Clin Exp Immunol; 1992 Nov; 90(2):293-9. PubMed ID: 1424289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum amyloid A induces CCL20 secretion in mononuclear cells through MAPK (p38 and ERK1/2) signaling pathways.
    Sandri S; Hatanaka E; Franco AG; Pedrosa AM; Monteiro HP; Campa A
    Immunol Lett; 2008 Nov; 121(1):22-6. PubMed ID: 18718487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An active metabolite of leflunomide, A77 1726, inhibits the production of serum amyloid A protein in human hepatocytes.
    Migita K; Miyashita T; Maeda Y; Nakamura M; Yatsuhashi H; Ishibashi H; Eguchi K
    Rheumatology (Oxford); 2005 Apr; 44(4):443-8. PubMed ID: 15695308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.